Cargando…
A systematic review of agomelatine-induced liver injury
Agomelatine is an antidepressant with a unique mechanism of action. Since its marketing in 2009, concerns have been raised regarding its potential to induce liver injury. The authors therefore address the need to comprehensively evaluate the potential risk posed by agomelatine of inducing liver inju...
Autores principales: | Freiesleben, Silka Dawn, Furczyk, Karolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407422/ https://www.ncbi.nlm.nih.gov/pubmed/25932327 http://dx.doi.org/10.1186/s40303-015-0011-7 |
Ejemplares similares
-
Efficacy and tolerability of agomelatine in the treatment of depression
por: Plesničar, Blanka Kores
Publicado: (2014) -
The Effects of Agomelatine Treatment on Lipopolysaccharide-Induced Septic Lung Injuries in Rats
por: Köse, Duygu, et al.
Publicado: (2021) -
CYP1A2 polymorphism may contribute to agomelatine-induced acute liver injury: Case report and review of the literature
por: Wang, Shushan, et al.
Publicado: (2021) -
Agomelatine: The evidence for its place in the treatment of depression
por: Eser, Daniela, et al.
Publicado: (2010) -
Technology for home dementia care: A prototype locating system put to the test
por: Megges, Herlind, et al.
Publicado: (2017)